Volume 56, Issue 3, Pages (September 2009)

Slides:

Advertisements

Similar presentations

Volume 61, Issue 5, Pages (May 2012)

Advertisements

Volume 68, Issue 6, Pages (December 2015)

Volume 61, Issue 3, Pages (March 2012)

Perioperative and Oncologic Outcomes of Nephrectomy and Caval Thrombectomy Using Extracorporeal Circulation and Deep Hypothermic Circulatory Arrest for.

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 62, Issue 4, Pages (October 2012)

Testosterone Therapy in Men With Prostate Cancer

Volume 58, Issue 1, Pages (July 2010)

Epidemiology and Risk Factors of Urothelial Bladder Cancer

The Effect of Other-cause Mortality Adjustment on Access to Alternative Treatment Modalities for Localized Prostate Cancer Among African American Patients

Volume 61, Issue 5, Pages (May 2012)

Volume 61, Issue 5, Pages (May 2012)

Volume 51, Issue 6, Pages (June 2007)

Volume 51, Issue 1, Pages (January 2007)

Volume 69, Issue 1, Pages (January 2016)

Volume 70, Issue 6, Pages (December 2016)

Increase in the Annual Rate of Newly Diagnosed Metastatic Prostate Cancer: A Contemporary Analysis of the Surveillance, Epidemiology and End Results Database

Volume 51, Issue 3, Pages (March 2007)

European Urology Oncology

Volume 70, Issue 5, Pages (November 2016)

Surgically Treated Retroperitoneal Sarcoma: A Population-based Competing Risks Analysis Sebastiano Nazzani, Felix Preisser, Marco Bandini, Michele Marchioni,

Volume 54, Issue 4, Pages (October 2008)

Volume 68, Issue 1, Pages (July 2015)

Volume 64, Issue 3, Pages (September 2013)

Volume 66, Issue 3, Pages (September 2014)

Volume 63, Issue 6, Pages (June 2013)

Volume 63, Issue 4, Pages (April 2013)

Volume 60, Issue 4, Pages (October 2011)

Volume 50, Issue 5, Pages (November 2006)

Volume 66, Issue 3, Pages (September 2014)

Volume 67, Issue 4, Pages (April 2015)

Volume 68, Issue 5, Pages (November 2015)

Nomograms for Bladder Cancer

Precystectomy Nomogram for Prediction of Advanced Bladder Cancer Stage

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 67, Issue 2, Pages (February 2015)

Volume 61, Issue 5, Pages (May 2012)

Volume 52, Issue 5, Pages (November 2007)

Volume 74, Issue 2, Pages (August 2018)

Volume 57, Issue 4, Pages (April 2010)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 68, Issue 1, Pages (July 2015)

Volume 61, Issue 6, Pages (June 2012)

Volume 61, Issue 5, Pages (May 2012)

Cytoreductive Radical Prostatectomy in Men with Prostate Cancer and Skeletal Metastases Axel Heidenreich, Nicola Fossati, David Pfister, Nazareno Suardi,

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 66, Issue 6, Pages (December 2014)

Volume 67, Issue 6, Pages (June 2015)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Volume 62, Issue 2, Pages (August 2012)

Volume 59, Issue 1, Pages (January 2011)

Volume 60, Issue 6, Pages (December 2011)

European Guidelines on Upper Tract Urothelial Carcinomas: 2013 Update

Volume 56, Issue 5, Pages (November 2009)

Volume 53, Issue 1, Pages (January 2008)

Volume 50, Issue 5, Pages (November 2006)

Volume 73, Issue 1, Pages (January 2018)

Volume 55, Issue 6, Pages (June 2009)

Testicular Cancer Variations in Time and Space in Europe

Volume 54, Issue 4, Pages (October 2008)

European Urology Oncology

European Urology is “Your” Journal

Epidemiology of Renal Cell Carcinoma

Psychotherapeutic Interventions Targeting Prostate Cancer Patients: A Systematic Review of the Literature Liliana Vartolomei, Shahrokh F. Shariat, Mihai.

The Start-Up of the Platinum Journal: A Fascinating Challenge

Volume 51, Issue 6, Pages (June 2007)

Volume 50, Issue 5, Pages (November 2006)

Economic Burden of Bladder Cancer Across the European Union

Volume 54, Issue 2, Pages (August 2008)

Volume 54, Issue 1, Pages (July 2008)

Presentation transcript:

Volume 56, Issue 3, Pages 512-519 (September 2009) The Extent of Lymphadenectomy Seems to Be Associated with Better Survival in Patients with Nonmetastatic Upper-Tract Urothelial Carcinoma: How Many Lymph Nodes Should Be Removed? Marco Roscigno, Shahrokh F. Shariat, Vitaly Margulis, Pierre Karakiewicz, Mesut Remzi, Eiji Kikuchi, Richard Zigeuner, Alon Weizer, Arthur Sagalowsky, Karim Bensalah, Jay D. Raman, Christian Bolenz, Wassim Kassou, Theresa M. Koppie, Christopher G. Wood, Jeffrey Wheat, Cord Langner, Casey K. Ng, Umberto Capitanio, Roberto Bertini, Mario I. Fernández, Shuji Mikami, Masaru Isida, Philipp Ströbel, Francesco Montorsi European Urology Volume 56, Issue 3, Pages 512-519 (September 2009) DOI: 10.1016/j.eururo.2009.06.004 Copyright © 2009 European Association of Urology Terms and Conditions

Fig. 1 The plots depict the (A) linear and (B) nonlinear effects of the number of lymph nodes removed on cause-specific mortality in 412 patients with pN0 upper-tract urothelial carcinoma. LN=lymph node. European Urology 2009 56, 512-519DOI: (10.1016/j.eururo.2009.06.004) Copyright © 2009 European Association of Urology Terms and Conditions

Fig. 2 Cancer-specific survival according to the number of lymph nodes removed in pN0 patients (n=412). CSM=cause-specific mortality; LN=lymph node. European Urology 2009 56, 512-519DOI: (10.1016/j.eururo.2009.06.004) Copyright © 2009 European Association of Urology Terms and Conditions